Scientific work

Prof. Dr. Ahmet Omma

304 publications. The source of the information is stated next to each publication.

Back to profile

  1. Comorbidity Profiles in Inflammatory Rheumatic Diseases: An Analytical Perspective

    International Journal of Clinical Practice, 2024

    DOI 10.1155/2024/3244597 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  2. Is the visceral adiposity index associated with the presence of cardiovascular risk scores and comorbidity in psoriatic disease?

    Ulusal Romatoloji Dergisi, 2024

    DOI 10.4274/raed.galenos.2024.83097 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  3. AB1293 FREQUENCY AND THE EFFECTS OF SPONDYLOARTHRITIS-SPECTRUM DISORDERS ON THE CLINICAL COURSE AND MANAGEMENT OF TAKAYASU ARTERITIS

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.5448 1 citation (OpenAlex) Source: OpenAlex

  4. FACIAL ERYTHEMA MAY NOT ALWAYS BE A MANIFESTATION OF THE PRIMARY CONDITION IN CONNECTIVE TISSUE DISEASES: KEEP DEMODEX IN MIND!

    2024

    DOI 10.22541/au.170668061.18884453/v1 Open-access full textSource: OpenAlex

  5. Effects of intrauterine device use on attack frequency and severity ın woman of reproductive age with familial Mediterranean fever

    Archives of Gynecology and Obstetrics, 2024

    DOI 10.1007/s00404-024-07413-5 PMID 38478158 Source: OpenAlex

  6. Coronavirus Disease 2019 Outcomes in Amyloid A Protein Amyloidosis Secondary to Rheumatic Conditions and Signs of Post- Coronavirus Disease 2019 Proteinuria Progression

    European Journal of Rheumatology, 2024

    DOI 10.5152/eurjrheum.2024.23050 PMID 38705968 Open-access full textSource: OpenAlex

  7. Assessment of venous disease with different venous disease specific scales in Behçet’s disease patients with deep vein thrombosis

    Phlebology The Journal of Venous Disease, 2024

    DOI 10.1177/02683555241257868 PMID 38810108 Source: OpenAlex

  8. AB1345 COMORBIDITY PROFILES IN INFLAMMATORY RHEUMATIC DISEASES: AN ANALYTICAL PERSPECTIVE

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.2373 Source: OpenAlex

  9. AB1327 VALIDATION OF THE 2022 ACR/EULAR CLASSIFICATION CRITERIA FOR LARGE-VESSEL VASCULITIS; CONFUSION OF CLASSIFICATION BETWEEN CERTAIN AGES REMAINS

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.5776 Source: OpenAlex

  10. AB0724 TOFACITINIB DRUG SURVIVAL MAY BE BETTER IN OBESE TNF INHIBITOR RESISTANT RA PATIENTS

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.1726 Source: OpenAlex

  11. POS0857 REMARKING THE OSTEOPOROSIS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS (AAV): DATA FROM EASTERN MEDITERRANEAN (TRVAS)

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3977 Source: OpenAlex

  12. AB1272 MANAGING OF ANCA-ASSOCIATED VASCULITIS: ADHERENCE TO TREATMENT GUIDELINES AND EARLY MODIFICATIONS, ARE WE THERE YET?

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.5318 Source: OpenAlex

  13. AB1328 IS THERE A NEED FOR ROUTINE IMAGING FOLLOW-UP IN PATIENTS WITH TAKAYASU ARTERITIS?

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.5892 Source: OpenAlex

  14. POS0933 THE FREQUENCY OF AORTIC AND MITRAL VALVE INVOLVEMENT IN PATIENTS WITH TAKAYASU ARTERITIS

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.5914 Source: OpenAlex

  15. AB0950 DRUG SURVIVAL AND PREDICTOR FACTORS OF DISCONTINUATION IN AXIAL SPONDYLOARTHRITIS PATIENTS RECEIVING CERTOLIZUMAB AND SECUKINUMAB

    Annals of the Rheumatic Diseases, 2024

    DOI 10.1136/annrheumdis-2024-eular.3290 Source: OpenAlex

  16. Romatolojide Güncel Tedaviler

    Akademisyen Kitabevi eBooks, 2024

    DOI 10.37609/akya.2736 Open-access full textSource: OpenAlex

  17. Is Regular Vascular Imaging Scheduled Essential in the Follow-Up of Takayasu Arteritis? A Large-Scale Multicenter Cohort Study

    Kocaeli Üniversitesi - AVESİS, 2024

    Source: OpenAlex

  18. Is Regular Vascular Imaging Scheduled Essential in the Follow-Up of Takayasu Arteritis? A Large-Scale Multicenter Cohort Study

    Bursa Uludag University - AVESIS, 2024

    Source: OpenAlex

  19. Biological Treatment May Be an Option as First Steroid-Sparing Agent in a Subgroup of Young Takayasu Arteritis Patients with Prominent Acute Phase Reactants and Constitutional Symptoms

    Kocaeli Üniversitesi - AVESİS, 2024

    Source: OpenAlex

  20. AB0777 PERFORMANCE OF 2022 ACR/EULAR GPA, EGPA AND MPA CLASSIFICATION CRITERIA IN TURKISH VASCULITIS STUDY GROUP PROSPECTIVE COHORT (TRVAS)

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.5370 Open-access full textSource: OpenAlex

  21. Evaluation of patients with antiphospholipid syndrome subsequently COVID-19 vaccinations: A retrospective cohort study

    International journal of rheumatic diseases, 2023

    DOI 10.1111/1756-185x.14490 PMID 36371485 8 citations (Europe PMC) Open-access full textSource: Europe PMC

  22. Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis

    Laboratory medicine, 2023

    DOI 10.1093/labmed/lmad019 PMID 37100766 5 citations (Europe PMC) Source: Europe PMC

  23. Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center

    Immunopharmacology and immunotoxicology, 2023

    DOI 10.1080/08923973.2022.2160729 PMID 36537308 3 citations (Europe PMC) Open-access full textSource: Europe PMC

  24. Comparative Metabolomic Profiles of Vascular Involvement in Behçet’s Disease

    European Journal of Rheumatology, 2023

    DOI 10.5152/eurjrheum.2023.23062 PMID 37850605 6 citations (OpenAlex) Open-access full textSource: OpenAlex

  25. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry

    Clinical and Experimental Rheumatology, 2023

    DOI 10.55563/clinexprheumatol/zr7s0g PMID 37976117 6 citations (OpenAlex) Source: OpenAlex

  26. Tofacitinib experience in patients with enteropathic arthritis

    Immunotherapy, 2023

    DOI 10.2217/imt-2022-0110 PMID 37009645 5 citations (OpenAlex) Source: OpenAlex

  27. Ustekinumab in Enteropathic Arthritis

    Immunotherapy, 2023

    DOI 10.2217/imt-2022-0197 PMID 37020400 5 citations (OpenAlex) Source: OpenAlex

  28. Non-criteria autoantibodies in antiphospholipid syndrome may be associated with underlying disease activity

    Irish Journal of Medical Science (1971 -), 2023

    DOI 10.1007/s11845-023-03519-y PMID 37737913 4 citations (OpenAlex) Source: OpenAlex

  29. COVID ‐19 disease frequency, risk factors, and re‐infection rates in patients with autoimmune rheumatic disease receiving rituximab

    International Journal of Rheumatic Diseases, 2023

    DOI 10.1111/1756-185x.14676 PMID 36942871 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  30. Effects of breast milk on Behçet's disease clinical features

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2023

    DOI 10.55730/1300-0144.5565 PMID 36945965 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  31. A single-center rheumatology experience of sarcoidosis: observations from 70 patients.

    Sarcoidosis vasculitis and diffuse lung diseases, 2023

    DOI 10.36141/svdld.v40i3.14063 PMID 37712373 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  32. The Possible Relation of Demodex and Facial Erythema in Connective Tissue Diseases

    Iranian Journal of Parasitology, 2023

    DOI 10.18502/ijpa.v18i2.13190 PMID 37583642 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  33. Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID)

    Clinical Rheumatology, 2023

    DOI 10.1007/s10067-022-06492-6 PMID 36637636 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  34. Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study

    Vaccines, 2023

    DOI 10.3390/vaccines11071234 PMID 37515050 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  35. Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry

    Clinical and Experimental Rheumatology, 2023

    DOI 10.55563/clinexprheumatol/2h6ma1 PMID 37650346 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  36. AB0756 IDENTIFICATION OF HISTOPATHOLOGIC FINDINGS OF PATIENTS WITH GIANT CELL ARTERITIS: A MULTICENTRE STUDY IN THE ERA OF 2022 ACR/EULAR CLASSIFICATION CRITERIA FOR GCA

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.1935 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  37. POS0219 COMPARISON OF METHOTREXATE AND AZATHIOPRINE AS THE FIRST STEROID-SPARING IMMUNOSUPPRESSIVE AGENT IN PATIENTS WITH TAKAYASU'S ARTERITIS

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.6172 Open-access full textSource: OpenAlex

  38. AB1691 BURDEN OF AFFECTED FACE IN PATIENTS WITH SYSTEMIC SCLEROSIS: A TRANSLATION AND VALIDATION STUDY IN TURKISH

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.5553 Open-access full textSource: OpenAlex

  39. AB1763-HPR RELIABILITY AND VALIDITY OF THE TURKISH VERSION OF SCLERODERMA SKIN PATIENT-REPORTED OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS

    Annals of the Rheumatic Diseases, 2023

    DOI 10.1136/annrheumdis-2023-eular.3450 Open-access full textSource: OpenAlex

  40. Rituximab use may indicate impaired quality of life in granulomatosis with polyangiitis

    Ulusal Romatoloji Dergisi, 2023

    DOI 10.4274/raed.galenos.2023.59244 Open-access full textSource: OpenAlex

  41. Evaluation of adult immunoglobulin A vasculitis with oxidative stress and inflammation biomarkers

    Medicine Science | International Medical Journal, 2023

    DOI 10.5455/medscience.2023.06.091 Open-access full textSource: OpenAlex

  42. Ulusal dev hücreli arterit veritabanı izlem verisi: Relaps oranı kontrollü çalışmalardan düşüktür.

    Kocaeli Üniversitesi - AVESİS, 2023

    Source: OpenAlex

  43. Takayasu arteritine eşlik eden spondiloartrit spektrumundaki hastalıkların sıklığı ve hastalık seyrine etkisi.

    Kocaeli Üniversitesi - AVESİS, 2023

    Source: OpenAlex

  44. IgA vaskülitinin çocuk ve erişkinlerde karşılaştırılması: Çok merkezli çalışma.

    Kocaeli Üniversitesi - AVESİS, 2023

    Source: OpenAlex

  45. Spondiloartropati hastalarında secukinumab ve sertolizumab tedavilerin karşılaştırılması

    AYBU AVESIS, 2023

    Source: OpenAlex

  46. An evaluation of the results of convalescent plasma therapy applied to pregnant womendiagnosed as COVID-19- positive in a pandemic center: A prospective cohort study

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022

    DOI 10.55730/1300-0144.5346 PMID 36326345 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  47. Hydroxychloroquine shortened hospital stay and reduced intensive care unit admissions in hospitalized COVID-19 patients

    The Journal of Infection in Developing Countries, 2022

    DOI 10.3855/jidc.14933 PMID 35192518 1 citation (Europe PMC) Open-access full textSource: ORCID

  48. Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: a case series with literature review

    Immunotherapy, 2022

    DOI 10.2217/imt-2021-0128 PMID 35152720 11 citations (Europe PMC) Source: Europe PMC

  49. Clinical course of idiopathic inflammatory myopathies in COVID-19 pandemic: a single-center experience

    Future virology, 2022

    DOI 10.2217/fvl-2021-0146 PMID 35747325 3 citations (Europe PMC) Open-access full textSource: Europe PMC

  50. Effects of anti-SARS-CoV-2 vaccination on safety and disease exacerbation in patients with Behçet syndrome in a monocentric cohort

    International journal of rheumatic diseases, 2022

    DOI 10.1111/1756-185x.14387 PMID 35851753 10 citations (Europe PMC) Open-access full textSource: Europe PMC